Pulmonary Arterial Hypertension Market Projected to Surge from USD 7.75 Billion (2024) to USD 11.63 Billion by 2032 as Demand for Advanced Therapies Intensifies
The global Pulmonary Arterial Hypertension (PAH) market, valued at approximately USD 7.75 billion in 2024, is expected to grow at a robust CAGR of around 5.2% to reach nearly USD 11.63 billion by 2032. Key drivers fueling...